Drug Research

BioMed X unveiled its new immunology discovery platform designed to allow for the accurate and fast identification of target antigens of human T cell receptors (TCRs). The platform is expected to be deployed via a collaborative model with pharmaceutical and...

Lonza, a partner to the pharmaceutical, biotech and nutraceutical markets, has completed a planned expansion of its bioconjugation facility in Visp, Switzerland. The expansion includes two manufacturing suites and supporting infrastructure to support an extended customer portfolio, including companies entering...

As per a market report by Reportlinker, the worldwide highly potent active pharmaceutical ingredient- HPAPI sector is anticipated to breach the $34.04 billion mark by 2026 at a CAGR of around 8.5%. HPAPIs are substances that cause a biological response...

Researchers at Northwestern University's International Institute for Nanotechnology (IIN) have devised a novel method for dramatically increasing the potency of practically any vaccine. The researchers used chemistry and nanotechnology to alter the structural placement of adjuvants and antigens on...

The Regenerative Medicine Advanced Therapies designation of RP-A501, which happens to be an adeno-associated virus-based gene therapy when it comes to the treatment of Danon disease, has been granted by the US Food and Drug Administration. According to Dr. Gaurav...

Evotec SE announced that the company has extended and expanded its integrated multi-target drug discovery agreement with data-driven biotech creation firm, Related Sciences (RS), to continue to grow their joint portfolio of drug development candidates through 2030, leveraging Evotec’s...

BD, a leading global medical technology company, announced a new instrument for single-cell multiomics analysis that will enable scientists to run high-throughput studies without sacrificing sample integrity – potentially accelerating time to discovery across a wide range of disciplines...